Taken together, despite varying cutoffs, these reports suggest variability in PD-L1 expression, which may be related to the techniques used to measure PD-L1 levels or inherent variability in PD-L1 expression among different NSCLC cohorts. This evidence concerns the gene CD274 and non-small cell lung carcinoma.